This clinical trial is for people who have moderate to severe hair loss from Alopecia Areata. Basic criteria are listed below. Click to sign up or request more info.
OFFICIAL TITLE:
A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Proof-of-Concept Trial of ADX-914 for the Treatment of Severe Alopecia Areata
Volunteers needed for a clinical trial lasting up to 40 week long with 18 office visits for a subQ investigational product. Up to $2,100.00 stipend available.
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) Greater than 18 years of age. Less than 75 years of age.
2.) Have MODERATE to SEVERE Alopecia Areata.
3.) Minimum SALT Score of 50 (to be determined at Screening Visit).
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Body Weight less than 105.6 lbs -OR- Body Weight over 264 lbs.
2.) Pregnant or lactating
3.) Active drug or alcohol dependence
ClinicalTrials.gov Identifier: NCT06018428
https://clinicaltrials.gov/study/NCT06018428?cond=alopecia%20areata&term=q32&rank=1
We love our patients, so feel free to visit during normal business hours.
Mon | 08:00 am – 05:00 pm | |
Tue | 08:00 am – 05:00 pm | |
Wed | 08:00 am – 05:00 pm | |
Thu | 08:00 am – 05:00 pm | |
Fri | 09:00 am – 03:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2024 Principle Research Solutions,llc - All Rights Reserved.
Your One-Stop Research SOLUTION
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.